This content is in French.
Eugenol: clove against cancer?
7 octobre 2025
By Ana Espino | Published on october 7, 2025 | 3 min read
#Oncology #Eugenol #Phenol
Cancer is one of the leading causes of death worldwide, characterized by uncontrolled cell proliferation, metastasis, and resistance to treatment. Despite progress in targeted therapies and immunotherapy, current treatments often remain toxic, costly, and associated with a reduced quality of life. The main challenge, therefore, is to discover safer anticancer agents that can effectively target tumor cells while sparing healthy tissues.
In this context, eugenol, a natural phenolic compound derived from clove (Syzygium aromaticum), has generated growing interest. With antioxidant, anti-inflammatory, and antiproliferative properties, it appears to be a promising candidate for the development of alternative anticancer therapies.
#Oncology #Eugenol #Phenol
Cancer is one of the leading causes of death worldwide, characterized by uncontrolled cell proliferation, metastasis, and resistance to treatment. Despite progress in targeted therapies and immunotherapy, current treatments often remain toxic, costly, and associated with a reduced quality of life. The main challenge, therefore, is to discover safer anticancer agents that can effectively target tumor cells while sparing healthy tissues.
In this context, eugenol, a natural phenolic compound derived from clove (Syzygium aromaticum), has generated growing interest. With antioxidant, anti-inflammatory, and antiproliferative properties, it appears to be a promising candidate for the development of alternative anticancer therapies.
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Noman, A. M., et al. (2025). Eugenol: An Insight Into the Anticancer Perspective and Pharmacological Aspects. Food science & nutrition, 13(8), e70727
View the source
